ArticleAmerican journal of translational research2024
Neutrophil-to-lymphocyte ratio combined with albumin to globulin ratio for predicting rheumatoid arthritis-associated pneumonia.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between neutrophil-to-lymphocyte ratio and the prognosis of patients with rheumatoid arthritis: a meta-analysis.Frontiers in immunology · 2026Pooled it
- Article
- Nonlinear Relationship of Leukocyte-to-Albumin Ratio with Disease Activity in Rheumatoid Arthritis.Journal of inflammation research · 2026Article
- The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis.Medicine · 2025Observational
- Association between albumin to Globulin ratio and pneumonia in patients with aneurysmal subarachnoid hemorrhage.Scientific reports · 2025Article
- Development and validation of a prognostic nomogram for predicting mortality risk in adult rheumatoid arthritis: an analysis of NHANES 1999-2018 data.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveRheumatoid arthritis-associated pneumonia (RAP) is a common complication of rheumatoid arthritis (RA) and is related to poor prognosis. Inflammation plays an important role in the development of RAP. This study aims to analyze and explore the predictive value of the neutrophil/lymphocyte ratio (NLR) combined with the albumin to globulin ratio (AGR) for assessing RAP.
methodsData for this study were collected retrospectively from the database of Xuancheng People's Hospital between February 2021 and November 2023. Patients with RAP were assigned to the observation group (n=78), while patients with rheumatoid arthritis (RA) alone were assigned to the control group (n=75). The differences in general clinical data, NLR, and AGR were compared between the two groups. Risk factors for RAP were analyzed using univariate and multivariate Logistic regression.
resultsThe observation group had significantly lower AGR levels and higher NLR levels compared to the control group (all P<0.05). Univariate and multivariate logistic regression analyses identified age (95% CI 1.265-3.468; P=0.007), glucocorticoid use (95% CI 1.187-3.187; P=0.009), usage of disease-modifying anti-rheumatic drugs (DMARDs) (95% CI 1.257-2.997; P=0.006), AGR (95% CI 1.147-3.578; P=0.012), NLR (95% CI 1.198-2.978; P=0.008) and course of disease (95% CI 11.178-2.971; P=0.005) as independent prognostic factors for RAP. In addition, the ROC curve analysis showed that joint detection of NLR and AGR had a sensitivity of 98.8% and specificity of 81.8% for predicting RAP.
conclusionNLR and AGR play significant roles in the occurrence and progression of RAP and can serve as predictive factors for early detection of RAP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.